Contents of this document
- Foreign exchange impact on overseas revenue¥-7,145 million
- Foreign exchange impact on overseas operating profit¥-1,436 million
- Foreign exchange impact on ordinary profit¥-1,687 million
- Foreign exchange impact on net income attributable to owners of the parent¥-998 million
- Increase in Selling, General and Administrative Expenses¥921 million
- Increase in Equity-Method Investment Income¥4,057 million
- AssumptionsExchange rateDetailsThe average exchange rate for January–March 2026 was used to convert the full-year forecast for the fiscal year ending March 2027.
- AssumptionsReference forecast based on the same exchange rates as the previous fiscal yearDetailsThe average exchange rate for January–December 2025 was used.
- Launch of New Yakult with 50% less sugar and calories
- Planned launch of Yakult 400 Immune Gut Health and Yakult 400 LT Immune Gut Health
- Launch of Muscat-flavored Yakult
- Capital investment plan for the fiscal year ending March 2027 (¥85.0 billion)
- Research into the feasibility of entering countries where the company has no presence, including local market research
- EPS¥150.72Year on year against the same period last year+¥0.24
- PER17.6 timesYear on year against the same period last year-1.4x
- ROE7.5 %Year on year against the same period last year-0.6ppt
- Dividend payout ratio (consolidated)46.4 %Year on year against the same period last year+3.9ppt
- Total overseas business sales volume29,002 Thousand bottles/dayYear on year against the same period last year+101.5%
- Total domestic dairy product sales volume8,933 Thousand bottles/dayYear on year against the same period last year+92.3%
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Net Sales | ¥486,425 million (YoY -2.7%) |
| Operating profit | ¥45,185 million (YoY -18.4%) |
| Ordinary income | ¥61,084 million (YoY -19.5%) |
| Net income | ¥44,228 million (net income attributable to owners of the parent) (YoY -2.9%) |
| Gross Profit Margin | 58.8 % |
| Operating profit margin | 9.3 % |
| Selling, general and administrative expenses | ¥241,050 million |
| Results for the three months of the current quarter | Period 1 January 2026 to 31 March 2026 / Net Sales ¥114,647 million (YoY +1.1%) / Operating profit ¥4,257 million (YoY -8.4%) / Operating profit by segment Beverages and food products (Japan) ¥4,026 million (YoY -40.2%) / Beverages and food products (Overseas) ¥6,812 million (YoY +58.8%) / Other ¥-1,690 million (YoY +90.4%) |
| Full-year earnings forecast | Fiscal year ending March 2027 Net Sales ¥527,000 million / Operating profit ¥44,000 million / Ordinary income ¥57,500 million / Profit attributable to owners of the parent ¥46,500 million / Equity-Method Income and Loss ¥2,800 million / Capital expenditure ¥85,000 million / Depreciation and amortization ¥32,000 million / Research and development costs ¥10,363 million |
| Segment results | Beverages and food products (Japan) Net Sales ¥229,604 million (YoY -5.5%) / Operating profit ¥27,668 million (YoY -26.1%) / Beverages and food products (Overseas) Net Sales ¥240,024 million (YoY +0.5%) / Operating profit ¥36,318 million (YoY -1.1%) / Other Net Sales ¥28,412 million (YoY -3.4%) / Operating profit ¥1,323 million |
| Breakdown of Factors Affecting the Change | Factors Foreign exchange impact on overseas revenue / Amount ¥-7,145 million, Factors Foreign exchange impact on overseas operating profit / Amount ¥-1,436 million, Factors Foreign exchange impact on ordinary profit / Amount ¥-1,687 million, Factors Foreign exchange impact on net income attributable to owners of the parent / Amount ¥-998 million, Factors Increase in Selling, General and Administrative Expenses / Amount ¥921 million, Factors Increase in Equity-Method Investment Income / Amount ¥4,057 million |
| Key KPIs | Indicator name EPS / Value ¥150.72 / Year on year against the same period last year +¥0.24, Indicator name PER / Value 17.6 times / Year on year against the same period last year -1.4x, Indicator name ROE / Value 7.5 % / Year on year against the same period last year -0.6ppt, Indicator name Dividend payout ratio (consolidated) / Value 46.4 % / Year on year against the same period last year +3.9ppt, Indicator name Total overseas business sales volume / Value 29,002 Thousand bottles/day / Year on year against the same period last year 101.5 Thousand bottles/day, Indicator name Total domestic dairy product sales volume / Value 8,933 Thousand bottles/day / Year on year against the same period last year 92.3 Thousand bottles/day |
| Unit price and quantity metrics | Unit prices are not disclosed; sales volumes by product for domestic dairy products and soft drinks are disclosed. |
| Number of stores and locations | Number of domestic sales companies 101 companies / Vending machines at period-end 34,886 Units / Total number of overseas factories 27 Factories |
| Number of employees | End of March 2026 2,912 people / End of September 2025 2,979 people / Change during the period -67 |
| Assumptions Underlying the Business Outlook | Assumptions Exchange rate / Details The average exchange rate for January–March 2026 was used to convert the full-year forecast for the fiscal year ending March 2027., Assumptions Reference forecast based on the same exchange rates as the previous fiscal year / Details The average exchange rate for January–December 2025 was used. |
| Financial targets | Actual ROE 7.5 % / Target Not disclosed |
| Payout ratio | 46.4 % |
| Capital expenditures | 80,809 Millions of yen (fiscal year ended March 2026 actual) |
| Market Size / Share | Population covered by sales Asia and Oceania 1,793,906 / Americas 561,586 / Europe 353,139 / Total 2,708,631 / As a percentage of population Asia and Oceania 1.22% / Americas 1.06% / Europe 0.21% / Total 1.05% |
| New initiatives | Launch of New Yakult with 50% less sugar and calories, Planned launch of Yakult 400 Immune Gut Health and Yakult 400 LT Immune Gut Health, Launch of Muscat-flavored Yakult, Capital investment plan for the fiscal year ending March 2027 (¥85.0 billion), Research into the feasibility of entering countries where the company has no presence, including local market research |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company cited a ¥1,337.9 million decline in revenue from beverages and food products in Japan, the impact of foreign exchange movements on the overseas business, which reduced revenue by ¥714.5 million and operating profit by ¥143.6 million, and a ¥92.1 million increase in selling, general and administrative expenses, among other factors.